ABSTRACT
INTRODUCTION
total number of test points. For each animal one slide from each liver lobe, and five randomly 149 chosen areas with most extensive damage in each slide were used for analysis.
150
Motor testing 151 Motor testing of experimental animals was performed by using test battery according to 152 Norton et al. (46) . This battery includes the following tests: withdrawal reflex, auditory startle 153 reflex, head shake reflex, corneal reflex, righting reflex, equilibrium test, grasping, placement, 154 general motor activity and exploratory signs/nose pokes. Animals were allowed to perform 155 righting reflex, equilibrium test, grasping and placement up to 300 s. General motor activity was 156 determined in special cages (55x35x30 cm) which floor was divided into nine quadrants. Motor 157 activity was expressed as a number of animal crosses from one quadrant to another during 10 158 minutes (each time the rat crossed into a different quadrant, a value of one was tallied).
159
Exploratory behavior was determined as a number of nose pokes during the same time interval
160
(each time the rat raised its body and poked its nose, a value of one was tallied). All the tests 161 were performed 0, 2, 4, 6 and 24 h after administration of the last dose of TAA and the total time 162 reqiured for the performance of all tests was maximally 20 min.
163
For each individual motor test animal could score up to 4 points. A score 4 was given if 164 animal performed test at 75-100% of the control value; score 3: at 50-75% of the control value; 165 score 2: at 25-50% of the control value; score 1: at 1-25% of the control value, while score 0 166 indicated that animal showed no response in the test. Control value was considered to be the 167 velocity of performance of the individual test by control animals (46).
168
Total behavioral score of the animal was calculated as the sum of all test scores (maximal 169 total score=40 and minimal total score=0). Coma was defined as an absence of corneal, sessions, the animal would be removed from the recording chamber and returned to its home 188 cage.
189

Western blot analysis
190
For Western blot analysis animals were sacrificed by rapid cervical dislocation and 191 decapitation without anesthesia. The brains were removed and two regions were dissected- 
221
The significance of the difference in volume density of damaged tissue and number of mitoses 222 was estimated using Kruskall-Wallis test followed by Mann-Whitney U post-hoc test.
223
For evaluation of the difference in motor tests, mean power spectra density and expression 224 of cellular markers two-way ANOVA with Tuckey post-hoc test and chi-square test were used.
225
The significance was considered significant if p<0.05. For statistical analysis computer software 
RESULTS
229
Blood ammonia concentration was significantly higher in TAA (86.7 ± 7.6 µmol/L) and areas mild inflammatory infiltrate and increased ductular structures can be observed (Fig. 2D ).
250
Mitoses were also noticed, but the number of mitoses was not significantly different in
251
FIN+TAA vs. control group (p>0.05; Table 1 ).
252
Motor tests
253
All animals from control, FIN and FIN+TAA group survived 24 h after treatment, while in 254 TAA group mortality in this period was 50% (9/18). Mortality started 8 h following the last dose 255 of TAA and was evident within the whole observation period. Total behavioral score was 256 significantly lower in TAA group vs. control at all time points (p<0.01), with the lowest median 257 24 h after treatment (4 (0, 4)). Although total behavioral score was significantly lower in 258 FIN+TAA vs. control group at all time points (p<0.05), the score in this group was significantly 259 higher by comparison with TAA group whenever the tests were performed (p<0.01). FIN alone 260 did not induce significant changes in total behavioral score when compared with control group 261 (p>0.05) ( Table 2 ).
The incidence of preserved vital reflexes (withdrawal, corneal, grasping and righting reflex) 263 was significantly lower in TAA by comparison with control group at all time points (p<0.01) 264 with the lowest incidence 24 h after TAA administration (10%). While vital reflexes were 265 significantly diminished in TAA group, these reflexes were preserved in all animals in FIN and 266 FIN+TAA group (Fig. 3A) .
267
Head shake and auditory startle reflex were significantly diminished in TAA vs. control 268 group at all time points (p<0.01). These reflexes were absent 24 h after TAA administration.
269
Although the incidence of preserved head shake and auditory startle reflexes was lower in 270 FIN+TAA than in control group at all time points (p<0.01), the extent of a decrease was 271 significantly lower than in TAA group (p<0.01). The lowest incidence of preserved head shake 272 and auditory startle reflex in FIN+TAA group was evident 4, 6 and 24 h after treatment (50%).
273
All animals from FIN group had completely preserved these reflexes (Fig. 3B) . Coma was 274 evident in 77.8% (7/9) of animals from TAA group 6 h after treatment and in 88.9% (8/9) of 275 animals 24 h after treatment, while in FIN+TAA group no animal (0/8) was comatose within 24 276 h after administration of the last dose of TAA.
277
Similar to head shake and auditory startle reflex, the incidence of preserved equilibrium and 278 placement test was significantly lower in TAA than in control group at all time points (p<0.01).
279
No animal had normal performance of these tests 24 h after TAA administration. All animals in 280 FIN+TAA group had preserved normal equilibrium and placement test 2 h after TAA treatment, 281 while the incidence of preserved tests was significantly lower 4, 6 and 24 h after treatment in 282 FIN+TAA vs. control group (p<0.01). However, at all time points the incidence of preserved 283 equilibrium and placement test was significantly higher in FIN+TAA when compared with TAA 284 group (p<0.01). All animals from FIN group normally performed these tests (Fig. 3C ).
General motor activity and exploratory behavior were significantly lower in TAA and
286
FIN+TAA groups by comparison with control group at all time points (p<0.01). However, 287 animals from FIN+TAA group had significantly greater motor activity when compared with 288 TAA group 4, 6 and 24 h after administration of the last dose of TAA (p<0.01; Fig. 4A ).
289
Exploratory behavior was, also, significantly higher in FIN+TAA vs. TAA group 6 and 24 h 290 after treatment (p<0.01; Fig. 4B ). No significant difference in the performance of these tests was (Fig. 6D) . The role of increased GABAergic transmission in the pathogenesis of HE prompted the 327 investigations of the potential therapeutic effects of modulators of GABA effects in the brain.
328
GABA A receptor antagonists and partial inverse benzodiazepine agonists were tested in humans 329 and several animal models of HE and revealed contradictory findings (1,3,15) . Another possible therapeutic approach may be an inhibition of neurosteroid synthesis in order to prevent 331 GABAergic hyperactivity. This is the first study that investigated the effects of FIN, 5α-332 reductase and neurosteroid synthesis inhibitor, on the course of HE.
333
The present study clearly showed that FIN improved motor disturbances and prevented the 334 development of the most severe forms of type A HE and lethal outcome after TAA treatment in 335 rats. FIN pretreatment alleviated a TAA-induced decrease in total behavioral score (Table 2 ) and 336 had variable effects on individual motor tests (Figs. 3 and 4) . The most prominent effect of FIN 337 pretreatment was the prevention of coma in TAA-treated rats, thus strongly suggesting that FIN 338 may prevent the development of the most severe forms of type A HE (stage IV).
339
This effect of FIN was further confirmed by EEG analysis. TAA-induced coma was 340 associated with low-voltage activity predominantly in the delta frequency range (Fig. 5) . 
407
TAA has different effects on GFAP expression in various brain regions (Fig. 6B) , thus 408 suggesting regional differences in astrocyte response to hyperammonemia. This is in accordance based on an increase in mean EEG voltage (Fig. 5) , accompanied with a decrease in NeuN 420 expression in the cortex, but not in the hippocampus (Fig. 6A ). An increase in EEG voltage Daily doses of FIN (50 mg/kg) and TAA (300 mg/kg) were administered intraperitoneally in three subsequent days, while in FIN+TAA group FIN was administered 2 h before every dose of TAA. Liver samples were collected 24 h after treatment and stereological analysis was performed by the point counting technique using a test system of 36 points. Volume density of damaged tissue was calculated from equation Pd/Pt, where Pd is a number of points falling on damaged area and Pt is a total number of test points. Hepatocytes in mitosis were counted in 7 randomly selected fields with minimal hepatocyte damage. Only cells with clear morphological characteristics of metaphase, anaphase, and telophase were counted.
Data are presented as medians with 25th and 75th percentiles in parentheses. Statistical significance of the difference was evaluated by Kruskall-Wallis nonparametric ANOVA with MannWhitney U post hoc test (** p<0.01 vs. control, # p<0.01 vs. TAA group). 
